Annovis Bio Inc. (ANVS) Social Stream



Annovis Bio Inc. (ANVS): $9.44

0.95 (+11.19%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

ANNOVIS BIO INC (ANVS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ANNOVIS BIO INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-22 1 $70 $70 $70 $7.39 847.23%
2022-04-08 1 $26 $26 $26 $7.39 251.83%
2022-08-09 2 $37 $26 $31.5 $7.39 326.25%
2023-04-04 3 $72 $26 $46 $7.39 522.46%
2023-10-13 2 $72 $40 $56 $7.39 657.78%
2023-10-20 3 $72 $26.001 $46 $7.39 522.46%
2023-11-13 4 $72 $26.001 $40.75 $7.39 451.42%

Price Target Last Issued April 8, 2022

The Trend in the Analyst Price Target


ANVS's average price target has moved down $15.25 over the prior 138 days.

Over the past 41 weeks, ANVS's average upside potential has been 357.24%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-21 2 72 40.000 56 15.81 254.21%
2023-05-12 2 72 40.000 56 14.09 297.44%
2023-06-28 2 72 40.000 56 14.16 295.48%
2023-10-13 2 72 40.000 56 7.86 612.47%
2023-10-20 4 72 26.001 46 8.58 436.13%

ANVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 40 months, ANVS's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how ANNOVIS BIO INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 58.72% of that group.
  • ANVS has a higher upside potential (average analyst target price relative to current price) than 917.87% of all US stocks.
  • ANNOVIS BIO INC's variance in analysts' estimates is lower than -428.61% of all US stocks.
  • ANNOVIS BIO INC's average analyst price target is greater than 843.57% of stocks in the small market cap category.

Stocks similar to ANNOVIS BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ETNB, GRTX, and RAPT.

Is ANVS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!